GW School of Medicine and Health Sciences and the GW MFA Serve as one of 24 participating trial sites for the NIAID’s COVAIL Trial

The GW School of Medicine and Health Sciences has been selected to serve as one of 24 participating sites for the Phase 2 clinical trial to evaluate additional COVID-19 booster shots in adults, including multiple vaccines based on viral variants such as Delta and Omicron.